Effects of Intensive cART During Acute/Early HIV Infection

NCT01154673 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Acute HIV Infection

Interventions

DRUG: raltegravir
DRUG: maraviroc
DRUG: emtricitabine 200mg /tenofovir 300mg
DRUG: lopinavir 400 mg/ritonavir 100mg

Sponsor

University of Toronto

Collaborators

[object Object]
[object Object]